Imatinib in Acute Ischaemic Stroke
NCT03639922
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1260
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischaemic Stroke
Interventions
DRUG:
Imatinib 400mg
DRUG:
Placebo Oral Tablet
Sponsor
Niaz Ahmed